| IPO Date | May 21, 2026 to May 25, 2026 |
| Listing Date | May 29, 2026 |
| Face Value | ₹ 10 / Share |
| Price Band | ₹ 132 to ₹ 139 / Share |
| Lot Size | 1000 Shares |
| Total Issue Size | 3772000 (Aggregating up to 52 ) |
| Fresh Issue | 3206000 (Aggregating up to 45 ) |
| Offer for Sale | 377000 (Aggregating up to 5) |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share holding pre issue | 9180001 |
| Share holding post issue | 12575001 |
| Market Maker portion |
Bio Medica Laboratories IPO opens on May 21, 2026, and closes on May 25, 2026.
| IPO Open Date | May 21, 2026 |
| IPO Close Date | May 25, 2026 |
| Basis of Allotment | May 26, 2026 |
| Initiation of Refunds | May 27, 2026 |
| Credit of Shares to Demat | May 27, 2026 |
| Listing Date | May 29, 2026 |
| Cut-off time for UPI mandate confirmation | -- |
Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | Rs.278,000 |
| Retail (Max) | 2 | 2,000 | Rs.278,000 |
| S-HNI (Min) | 3 | 3,000 | Rs.417,000 |
| S-HNI (Max) | 7 | 7,000 | Rs.973,000 |
| B-HNI (Min) | 8 | 8,000 | Rs.1,112,000 |
| HNI (Min) |
| Share Holding Pre Issue | 9180001 |
| Share Holding Post Issue | 12575001 |
Bio Medica Laboratories IPO comprises a total issue size of 37,72,000 shares. The net offer to the public is 35,83,000 shares, after excluding 1,89,000 shares allotted on a firm basis. Of the Net offer 36,000 (1.00%) are allocated to QIB, 17,55,000 (48.98%) allocated to NII 17,92,000 (50.01%) allocated to RII.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | 189000 |
5.01 |
| Other Shares Offered | |
|
| QIB Shares Offered | 36000 1.00 |
0.95 |
| NII (HNI) Shares Offered | 1755000 48.98 |
46.53 |
| bNII > ₹10L | 1170000 |
31.02 |
| sNII < ₹10L | 585000 |
15.51 |
| Retail Shares Offered | 1792000 50.01 |
47.51 |
| Employee Shares Offered | |
|
| Total Shares Offered | 3772000 100.00 |
| Bid Date | |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | |
| Anchor lock-in period end date for 50% shares (30 Days) | |
| Anchor lock-in period end date for remaining shares (90 Days) |
Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable forms.der injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare.
Product portfolio:
It offers comprehensive range of products, including generic drugs, branded pharmaceuticals, over the counter (OTC) products, and other medications.
The company operates on a B2B model, focusing exclusively on contract manufacturing. It develop formulations for various companies in accordance with their specific requirements and product specifications. It is certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificate issued by the Food & Drugs Administration, Madhya Pradesh.
It has two manufacturing facilities in Indore, Madhya Pradesh.
Competitive Strengths
| KPI | Values |
|---|---|
| ROE | 54.41 |
| ROCE | 23.22 |
| Debt/Equity | 2.23 |
| RoNW | 54.41 |
| P/BV | 8.66 |
| PAT Margin (%) | 30.35 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 10.67 | 10.33 |
| P/E (x) | 13.03 | 13.45 |
Mukesh Mehta and Pradeep Mehta
Bio Medica Laboratories Ltd. Address Plot No.11B-11C Sector-E, Sanwer Road Industrial Area, Industrial Estate Indore, Madhya Pradesh, 452015
|